Bank of America’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-83,046
| Closed | -$1.58M | – | 7694 |
|
|
2019
Q1 | $1.58M | Buy |
83,046
+80,146
| +2,764% | +$1.3M | ﹤0.01% | 4179 |
|
|
2018
Q4 | $39K | Sell |
2,900
-2,014
| -41% | -$22.5K | ﹤0.01% | 6302 |
|
|
2018
Q3 | $55K | Buy |
+4,914
| New | +$49.2K | ﹤0.01% | 6179 |
|
|
2017
Q1 | – | Sell |
-16,874
| Closed | -$83K | – | 7593 |
|
|
2016
Q4 | $83K | Buy |
16,874
+3,746
| +29% | +$19.2K | ﹤0.01% | 5712 |
|
|
2016
Q3 | $65K | Sell |
13,128
-2,458
| -16% | -$12.6K | ﹤0.01% | 5632 |
|
|
2016
Q2 | $79K | Buy |
15,586
+3,519
| +29% | +$18.9K | ﹤0.01% | 5651 |
|
|
2016
Q1 | $69K | Sell |
12,067
-7,096
| -37% | -$49.6K | ﹤0.01% | 5658 |
|
|
2015
Q4 | $199K | Buy |
19,163
+6,632
| +53% | +$90K | ﹤0.01% | 5384 |
|
|
2015
Q3 | $231K | Sell |
12,531
-519
| -4% | -$10K | ﹤0.01% | 5252 |
|
|
2015
Q2 | $254K | Buy |
13,050
+2,617
| +25% | +$46.3K | ﹤0.01% | 5121 |
|
|
2015
Q1 | $183K | Sell |
10,433
-1,834
| -15% | -$30.8K | ﹤0.01% | 4980 |
|
|
2014
Q4 | $196K | Buy |
12,267
+154
| +1% | +$2.06K | ﹤0.01% | 5384 |
|
|
2014
Q3 | $152K | Buy |
12,113
+2,046
| +20% | +$29.2K | ﹤0.01% | 5653 |
|
|
2014
Q2 | $158K | Buy |
10,067
+777
| +8% | +$11.4K | ﹤0.01% | 5757 |
|
|
2014
Q1 | $122K | Sell |
9,290
-2,466
| -21% | -$38.6K | ﹤0.01% | 5829 |
|
|
2013
Q4 | $189K | Sell |
11,756
-21,253
| -64% | -$339K | ﹤0.01% | 5654 |
|
|
2013
Q3 | $549K | Buy |
33,009
+17,310
| +110% | +$256K | ﹤0.01% | 4543 |
|
|
2013
Q2 | $158K | Buy |
+15,699
| New | +$165K | ﹤0.01% | 5840 |
|
Other funds holding OSIR
Bank of America's OSIR Position: Q2 2019 in Review
Bank of America sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 83,046 shares — an estimated $1.58M sold.
Bank of America first reported a position in OSIR in Q2 2013 and held it in 18 quarters. The position peaked at $1.58M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.
- Bank of America reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Bank of America sold 83,046 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.58M.
- Bank of America first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- Bank of America's Osiris Therapeutics, Inc. Common Stock position peaked at $1.58M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.